Abstract

SGLT2阻害薬を4年間継続投与した糖尿病合併代謝関連脂肪性肝疾患（MASLD）症例の検討

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call